supported by the National Key Plan for Scientific Research and Development of China(2021YFC2501204);the National Key R&D Program of China(2021YFC2502100);the National Natural Science Foundation of China(81873785,82071439,81974202,U20A20355);Technology Major Project of Hunan Provincial Science and Technology Department(2021SK1010);the Innovation-driven Team Project from Central South University(2020CX016);the Innovative Team Program from the Department of Science&Technology of Hunan Province(2019RS1010).
Parkinson’s disease(PD)is the second most common neurodegenerative disease.The development of PD is closely linked to genetic and environmental factors,with GBA1 variants being the most common genetic risk.Mutations ...
funded by the Medical Research Council UK(MR/L010593);Alzheimer’s Research UK(Dementia Consortium Grant ARUK-DC2017-4,Network Grant G-102212);the Wellcome Trust(Wellcome Institutional Partnership Award 222062/Z/20/Z).
Neurodegenerative diseases are associated with chronic neuroinflammation in the brain,which can result in microglial phagocytosis of live synapses and neurons that may contribute to cognitive deficits and neuronal los...
Neurodegenerative disorders are typically“split”based on their hallmark clinical,anatomical,and pathological features,but they can also be“lumped”by a shared feature of impaired mitochondrial biology.This leads us...
supported by the Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission(23Y11906600);the Shanghai Natural Science Foundation(22ZR147750);the Innovative Clinical Research Project of Shanghai Changzheng Hospital(2023YJBF-PY13,2020YLCYJ-Y02,2020CZWJFW12);the Doctoral Innovation Fund of Shanghai Changzheng Hospital(BSCX2023-19,BSCX2022-34).
The diagnosis of neurodegenerative diseases(NDDs)remains challenging,and existing therapeutic approaches demonstrate little efficacy.NDD drug delivery can be achieved through the utilization of nanostructures,hence en...
funded by intramural funds with no role in writing of the manuscript.
There is increasing evidence for blood-brain barrier(BBB)alterations in Parkinson’s disease(PD),the second most common neurodegenerative disorder with rapidly rising prevalence.Altered tight junction and transporter ...
supported by National Natural Science Foundation of China(81870856,81870992,82071416,82071417,82188101,32171236);Central Government Guiding Local Science and Technology Development Projects(ZYYD2022C17);Key Research and Development Program of Guangzhou(2023B03J0631);Municipal University(Faculty)Joint Funding Project(202102010010);Municipal and University(Institute)Jointly Funded Project for Basic and Applied Basic Research(202201020472);Guangdong Basic and Applied Basic Research Foundation(2021B1515140026,2022B1515230004);the Science and Technology Commission of Shanghai Municipality(STCSM)(20XD1425000,2019SHZDZX02 and 22JC1410400).
Background Seed amplification assays(SAA)enable the amplification of pathological misfolded proteins,includ‑ingα-synuclein(αSyn),in both tissue homogenates and body fluids of Parkinson’s disease(PD)patients.SAA inv...
supported in part by the Intramural Research Program of the National Institute on Aging(NIA),the Center for Alzheimer’s and Related Dementias(CARD),within the Intramural Research Program of the National Institute on Aging and the National Institute of Neurological Disorders and Stroke(AG000546).
Parkinson’s disease(PD)diagnosis is based solely on clinical presentation[1].Therefore,diagnostic and prog-nostic biomarkers are needed.In recent years,seeding aggregation assays(SAA)have demonstrated the ability to ...
support from the French Agence Nationale de la Recherche(ANR),under grant ANR-22-CE16-0002(project ASAPS);supported by the Center of Excellence in Neurodegeneration(CoEN)Bordeaux Initiative for Neurodegenerative Disorders(BIND)reference CHUBX 2022/07,by the MSA Coalition Global Seed Grant reference MSAC-2022-12-005(project FibrilloScreen).
Parkinson’s disease(PD)and multiple system atrophy(MSA)are distinct neurodegenerative disorders sharing the accumulation of pathological alpha-synuclein(α-syn)amyloids in neurons or glial cells.Amyloidogenesis arise...
Background Degeneration of the locus coeruleus(LC)noradrenergic system contributes to clinical symptoms in Alzheimer’s disease(AD)and Parkinson’s disease(PD).Diffusion magnetic resonance imaging(MRI)has the potentia...
supported in part by grants from the National Natural Science Foundation of China(82171401,81971187,81971183,82371414);Shanghai Municipal Science and Technology Major Project(2018SHZDZX05).
Background Little is known about the impact of the COVID-19 pandemic on patients with Parkinson’s disease(PD)at different stages of the pandemic.This study aims to assess the lives and disease status of PD patients d...